Citation: Kn. Simpson et Rl. Lavallee, ANTIRETROVIRAL DRUG COST OFFSETS IN 7 DEVELOPED-COUNTRIES - SAQUINAVIR, ZALCITABINE, AND ZIDOVUDINE, AIDS, 10, 1996, pp. 66-66
Citation: Da. Revicki et al., EVALUATING THE QUALITY-OF-LIFE ASSOCIATED WITH RIFABUTIN PROPHYLAXIS FOR MYCOBACTERIUM-AVIUM COMPLEX IN PERSONS WITH AIDS - COMBINING Q-TWIST AND MULTIATTRIBUTE UTILITY TECHNIQUES, Quality of life research, 4(4), 1995, pp. 309-318
Citation: Da. Revicki et al., QUALITY-OF-LIFE IN RIFABUTIN PROPHYLAXIS FOR MYCOBACTERIUM-AVIUM COMPLEX IN PEOPLE WITH AIDS, Quality of life research, 3(1), 1994, pp. 44-44